Kate Hermans, Ambrx Biopharma interim CEO

Biotech lay­offs con­tin­ue as Am­brx cuts staff and part of its pipeline to ex­tend its cash

It’s been no se­cret that this year has been rough for biotechs and em­ploy­ees, as com­pa­nies have been cut­ting costs and head­counts through­out the year …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA